Jagson Pal Pharmaceuticals Limited., a active public limited company, was established on 17 August 1978 in New Delhi, Delhi, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: L74899DL1978PLC009181. Registered under ROC Roc Delhi. it is listed on BSE: 507789 and NSE: JAGSNPHARM. It has an authorized capital of ₹25.00 Cr and a paid-up capital of ₹13.34 Cr.
Formerly known as Jagson Pal Pharmaceuticals Private Limited. It upholds a compliant status. In 2024, it reported revenue of ₹217.98 Cr and a net worth of ₹187.40 Cr. Employing 1,308 professional, Its leadership includes Pallavi Dinodia Gupta (Director), Radhika Carlton Pereira (Director), Debasis Bikash Nandy (Director). Past directors included Ishpal Singh Ghai, Bharat Sinh, Surinder Kumar Goyal. It holds no open charges and ₹80.80 Cr settled loans. Its latest AGM occurred on 18 September 2024, with the balance sheet filed on 31 March 2024. It is based at Innov8 3Rd Floor, Plot No. 211, Okhla Phase-3, New Delhi, New Delhi, Delhi, 110020.
L74899DL1978PLC009181
009181
17 August 1978
₹25.00 Cr
₹13.34 Cr
Roc Delhi
Listed (BSE: 507789, NSE: JAGSNPHARM)
Active
Explore comprehensive insights into Jagson Pal Pharmaceuticals Limited. — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pallavi Dinodia Gupta | Director | 29 Jun 2022 | Current |
| Radhika Carlton Pereira | Director | 29 Jun 2022 | Current |
| Debasis Bikash Nandy | Director | 29 Jun 2022 | Current |
| Prithipal Singh Kochhar | Nominee Director | 29 Jun 2022 | Current |
| Harsha Raghavan | Director | 29 Jun 2022 | Current |
| Manish Gupta | Managing Director | 16 Jul 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2017 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2017 | Past |
| Pramod Abcsdd | Director | 14 Feb 2017 | Past |
| Pramod Abcsdd | Director | 31 Mar 2013 | Past |
| Pramod Abcsdd | Cfo | 22 Jan 2025 | Past |
| Pramod Abcsdd | Cfo(Kmp) | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Jagson Pal Pharmaceuticals Limited., for the financial year ended 2024, experienced significant reduction in revenue, with a 10.09% decrease. The company also saw a substantial fall in profitability, with a 15.94% decrease in profit. The company's net worth Soared by an impressive increase of 17.94%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Jagson Pal Pharmaceuticals had a promoter holding of 68.35% and a public holding of 31.64%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹808,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Oct 2010 | Punjab & Sind Bank | ₹6.70 Cr | Satisfied |
| 26 Oct 2010 | Punjab & Sind Bank | ₹31.90 Cr | Satisfied |
| 26 Oct 2010 | Punjab & Sind Bank | ₹3.00 M | Satisfied |
| 28 Jun 2006 | Others | ₹19.90 Cr | Satisfied |
| 28 Jun 2006 | Punjab & Sind Bank | ₹22.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Jagson Pal Pharmaceuticals has a workforce of 1308 employees as of Feb 28, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Jagson Pal Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jagson Pal Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Nirav Niranjankumar Vora was appointed as a Cfo was appointed as a Cfo on 04 Nov 2025 & has been associated with this company since 25 days . was documented.
Pratham Rawal was appointed as a Company Secretary was appointed as a Company Secretary on 26 Mar 2025 & has been associated with this company since 8 months 5 days . was recorded as a recent event.
Jagson Pal Pharmaceuticals Limited. last Annual general meeting of members was held on 18 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Jagson Pal Pharmaceuticals Limited. has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
Progress on Manish Gupta was appointed as a Managing Director was appointed as a Managing Director on 16 Jul 2022 & has been associated with this company since 3 years 4 months . was documented.
Pallavi Dinodia Gupta was appointed as a Director was appointed as a Director on 29 Jun 2022 & has been associated with this company since 3 years 5 months . was recorded as a recent event.
Jagsonpal Pharmaceuticals Ltd has informed BSE that Dr. Surinder Kumar Goyal, Director has resigned from Directorship of the Company w.e.f. February 14, 2017, his resignation has been approved by the Board of Directors in their meeting held on February 14, 2017. (Copy of resignation & resolution is enclosed)..
Jagsonpal Pharmaceuticals Ltd has informed BSE about Outcome of Board Meeting held on February 14, 2017..
The CIN of Jagson Pal Pharmaceuticals Limited. is L74899DL1978PLC009181.
Jagson Pal Pharmaceuticals Limited. is headquartered at Innov8 3Rd Floor, Plot No. 211, Okhla Phase-3, New Delhi, New Delhi, Delhi, 110020.
Jagson Pal Pharmaceuticals Limited. was incorporated on 17 August 1978.
The current directors of Jagson Pal Pharmaceuticals Limited. are
The primary industry of Jagson Pal Pharmaceuticals Limited. is Manufacturing.
Jagson Pal Pharmaceuticals Limited. is listed. It is listed on BSE: 507789 and NSE: JAGSNPHARM.
The authorized capital of Jagson Pal Pharmaceuticals Limited. is ₹25.00 Cr, and the paid-up capital is ₹13.34 Cr.
The compliance status of Jagson Pal Pharmaceuticals Limited. is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX